Penumbra, Inc. (PEN) Stock Price

PENStock
$321.68+18.40%52W
Market Cap$12.67B
P/E72.31x
PEG Ratio4.40
Div yield
Beta0.70

PEN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-17.20%
Price vs S&P 500 (4W)-1.96%
PEG Ratio4.40
VGM Score42.87
P/E Ratio (Annual)72.31x

PEN Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q2 2026$1.18$1.01-14.42%(-$0.17)
Q1 2026$1.06$1.01-4.63%(-$0.05)
Q4 2025$1.11$1.18+6.06%(+$0.07)
Q3 2025$0.92$0.97+5.33%(+$0.05)
Q2 2025$0.82$0.86+4.71%(+$0.04)

PEN Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
3.50
3.43
3.43
3.35

Industry Peers — Surgical & Medical Instruments(140)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
PENPenumbra, Inc.
DCC$321.68
SYKStryker CorporationCBC$330.69
MMM3M CompanyCDC$174.34
BSXBoston Scientific Corp.CBD$46.84
BDXBecton, Dickinson and Co.BDB$189.52
MDLNMedline Inc. Class A common stockCDC$35.28
RMDResMed Inc.CBB$240.33
DXCMDexCom, Inc.DBB$90.82
WSTWest Pharmaceutical Services, Inc.DCB$337.47
SOLVSolventum CorporationCCB$91.12
BAXBaxter International Inc.BDB$26.13

About Penumbra, Inc.

US-based Penumbra manufactures minimally invasive medical devices for mechanical removal of blood clots in acute care settings. The company's thrombectomy and embolization devices address stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular conditions, sold primarily to hospitals and physicians.